New 2026 program information covers self-pay pricing tiers, HSA/FSA eligibility, compounded semaglutide and tirzepatide ...
Neovascular age-related macular degeneration (nAMD) is a leading cause of irreversible vision impairment in adults, affecting ...
From once-a-week insulin to once-a-month weight loss injections, a new era of convenience is reshaping how doctors treat ...
Amgen (AMGN) stock climbs as MariTide GLP-1 trials demonstrate nearly 20% weight loss. Truist raises price target to $325 ...
For past 2 years, GLP-1 medications have been a fixture of consumer trend analysis, discussed by everyone from CNBC to ...
For the past 7 years, pharmaceuticals that work as glucagon-like peptide 1 (GLP-1) receptor agonists have dominated the weight-loss and diabetes markets. These drugs, currently so ...
About 7,300 years ago, a volcano off Japan's Kyushu island unleashed what remains the largest known eruption of the Holocene, ...
By reducing dissociation and sedation risk, ALA-3000 may eliminate the =2-hour post-dose monitoring requirement, reducing clinic operating costs, improving patient ...
Primary and Key Secondary Endpoints Met 77% of Patients Achieved Highly Statistically Significant Proptosis Response Study Showed Clinically Meaningful Reduction ...
Jim Newman, a former NASA astronaut and current professor at the Naval Postgraduate School, discusses the Artemis II crew, ...
From the September 1984 issue of Car and Driver. What we have here is one hell of a nice vehicle for grown-ups. The Peugeot ...
A phase 3 trial of patients with moderate-to-severe TED has shown that subcutaneous injection of Tepezza by way of an on-body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results